• α-Linolenic Acid: From Lipid Flux to Assay Design

  2026-08-17

  Explore how α-Linolenic Acid and ALA can be positioned in lipid, cardiovascular, inflammatory, and cancer research. This guide connects biochemical identity with assay design while carefully distinguishing evidence for ALA from findings on arachidonic acid and humoral immunity.

• Breast Cancer Dependence on MCL-1: Study Insights

  2026-08-17

  This study separates the canonical apoptotic function of MCL-1 from its proposed non-apoptotic activities in established breast tumors. Genetic deletion, selective pharmacological inhibition, and BAX/BAK epistasis show that tumor dependence on MCL-1 is principally mediated through mitochondrial apoptosis, while additional results connect MCL-1 with breast cancer stem-cell activity.

• Thymoquinone and Doxorubicin Cardiotoxicity

  2026-08-16

  The reference study provides initial in vivo evidence that thymoquinone protects mouse hearts from doxorubicin-associated injury. Its findings connect Nrf2/HO-1 activation, improved antioxidant defenses, reduced ferroptosis-associated changes, and preservation of mitochondrial structure, offering a mechanistic framework for preclinical cardiotoxicity research.

• ABT-888 (Veliparib): A DDR Decision Framework

  2026-08-15

  ABT-888 (Veliparib) is a selective PARP1/2 inhibitor for studying DNA repair inhibition and combination sensitivity. This article develops an evidence-based assay framework that connects colorectal cancer research and MSI tumor models with lessons from acute leukemia studies.

• FK866 (APO866): Reading NAD Dependency

  2026-08-14

  FK866 (APO866) is a precise NAMPT inhibitor for studying NAD depletion, mitochondrial stress, and selective cancer-cell vulnerability. This article offers an interpretation-first framework connecting AML models with emerging insights into PARP inhibitor resistance, while distinguishing established evidence from testable hypotheses.

• Exemestane Workflows for Aromatase Research

  2026-08-14

  Build reproducible aromatase assays with Exemestane, an irreversible steroidal aromatase inhibitor suited to biochemical, cellular, and translational breast cancer research. This guide combines concentration planning, washout experiments, estrogen readouts, and troubleshooting for stronger estrogen biosynthesis inhibition data.

• Curcumol, SAM, and Autophagic HSC Death

  2026-08-13

  The reference study identifies disrupted methionine metabolism as a mechanistic link between curcumol exposure and autophagy-dependent death of hepatic stellate cells. Its SAM-rescue experiments suggest that methionine-cycle impairment contributes functionally to the antifibrotic phenotype, while also highlighting the need to distinguish pathway-associated changes from direct metabolic-flux measurements.

• DNA Damage Biomarkers Improve Micronucleus Assays

  2026-08-13

  Avlasevich and colleagues combined flow-cytometric micronucleus scoring with DNA damage response and cytotoxicity biomarkers to clarify genotoxic mode of action. Across reference chemicals tested with and without metabolic activation, requiring concordant micronucleus and MultiFlow responses substantially improved specificity while preserving sensitivity.

• Optimized hiPSC-Derived Platelet Differentiation

  2026-08-12

  This 2026 study presents an optimized differentiation scheme for generating functional megakaryocytes and platelets from human induced pluripotent stem cells. By increasing embryoid body input, introducing human platelet lysate and small-molecule substitutions, and promoting megakaryocyte maturation, the protocol improves yield, shortens production time, and lowers reported costs.

• Acifran as a Receptor-Resolved Lipid Probe

  2026-08-12

  Acifran is a mechanistically informative probe for HCAR2/HCAR3 signaling and lipid metabolism research. This article translates recent cryo-EM findings into receptor-paired assay strategies, compound-handling guidance, and more rigorous interpretation of lipid signaling data.

• Thiazovivin: ROCK Inhibitor Workflow Guide

  2026-08-11

  Thiazovivin (SKU A5506) is a ROCK inhibitor for research workflows involving fibroblast reprogramming and human embryonic stem cell recovery after trypsinization. It should be optimized as a research reagent rather than treated as a universal or clinical protocol component, because the supplied dossier does not define a validated working concentration or exposure schedule.

• Caspase-3–NDUFS1 Axis in Trichothecene ROS

  2026-08-11

  This preprint identifies a caspase-3/NDUFS1 pathway that links apoptotic signaling to mitochondrial complex I disruption and shows how ERO1α-derived endoplasmic reticulum stress may reinforce trichothecene-induced ROS accumulation. The findings provide a mechanistic framework for studying DON- and T-2 toxin-associated liver injury, while requiring independent validation because the study has not yet been peer reviewed.

• Sulfonamide Inhibition of hPON1: Study Insights

  2026-08-10

  A 2017 study systematically compared six sulfonamides as inhibitors of purified human serum paraoxonase 1 (hPON1), identifying distinct noncompetitive, mixed-type, and competitive inhibition patterns. Sulfisomidine showed mixed-type inhibition, providing a useful mechanistic basis for enzyme kinetics and for interpreting how sulfonamide chemistry may intersect with oxidative and lipid-related biology.

• Ceftolozane-Tazobactam for Nosocomial Pneumonia

  2026-08-09

  The reference review explains how ceftolozane-tazobactam combines anti-pseudomonal cephalosporin activity with beta-lactamase inhibition to address difficult nosocomial pneumonia pathogens. Its synthesis of structural, susceptibility, pharmacokinetic-pharmacodynamic, and clinical evidence supports targeted use against resistant Pseudomonas aeruginosa while clarifying important limits involving ESBLs, carbapenemases, and post-hoc clinical analyses.

• SP2509 for Reliable AML Epigenetics

  2026-08-08

  SP2509 (SKU B4894) offers a data-grounded approach to LSD1 inhibition in acute myeloid leukemia research, with nanomolar biochemical potency, defined solubility, and practical storage guidance. This scenario-based guide helps researchers connect assay design, compound handling, mechanistic readouts, and vendor evaluation without overstating cellular or translational conclusions.

16362 records 1/1091 page Next 12345 下5页 Last page